| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $70.1M | +10.4% |
| SG&A Expense | $31.8M | -18.7% |
| Operating Income | -$101.9M | +0.7% |
| Pre-tax Income | -$88.6M | +1.5% |
| Income Tax | $260K | +8.8% |
| Net Income | -$88.9M | +1.5% |
| EPS (Basic) | -$1.12 | +11.8% |
| EPS (Diluted) | -$1.12 | +11.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $161.4M | +102.0% |
| Short-term Investments | $196.7M | +7.2% |
| Current Assets | $362.1M | +35.4% |
| Total Assets | $363.9M | +35.5% |
| Current Liabilities | $15.7M | +31.0% |
| Total Liabilities | $18.1M | +37.3% |
| Stockholders' Equity | $345.9M | +35.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.0M | -3.9% |
| Capital Expenditures | $42K | -19.2% |
| Investing Cash Flow | -$12.4M | +67.3% |
| Financing Cash Flow | $164.0M | +290.9% |
| Free Cash Flow | -$70.1M | -3.9% |